5892
A. Bakthavachalam et al. / Tetrahedron 70 (2014) 5884e5894
647; HRMS (ESI [MþNa]): 337.1526 (calcd for C18H22N2O3Na:
2H), 7.66 (dd, J¼5.6, 3.2 Hz, 2H), 7.48e7.44 (m, 2H), 7.35 (t, J¼7.4 Hz,
2H), 7.30e7.25 (m, 1H), 4.86 (q, J¼12.0 Hz, 2H), 4.00 (dd, J¼9.0,
5.4 Hz, 1H), 2.90 (d, J¼7.6 Hz, 1H), 2.87e2.81 (m, 1H), 2.33 (dt, J¼9.6,
4.9 Hz, 1H), 1.89e1.74 (m, 2H), 1.51 (d, J¼6.8 Hz, 1H), 1.35e1.21 (m,
337.1523).
4.6.3. 2-(2-(Hydroxymethyl)-3-propylaziridin-1-yl)-isoindoline-1,3-
dione (2c). 1H NMR (400 MHz, CDCl3):
d
7.72 (s, 2H), 7.66 (dd, J¼4.8,
2H); 13C NMR (100 MHz, CDCl3):
d 165.08, 138.57, 133.97, 130.56,
3.2 Hz, 2H), 3.93 (br s,1H), 3.63e3.58 (m,1H), 3.44 (br s,1H), 2.88 (t,
J¼7.2 Hz, 1H), 2.57e2.55 (m, 1H), 1.75e1.47 (m, 4H), 0.98 (t,
128.36, 127.91, 127.54, 122.94, 72.89, 70.89, 46.57, 44.63, 27.74,
23.02,15.88; IR (neat) cmꢁ1 3032, 2942, 2870,1767,1715,1376,1154,
889, 706; HRMS (EI) : 348.1480 (calcd for C21H20N2O3: 348.1474).
J¼7.2 Hz, 3H); 13C NMR (100 MHz, CDCl3):
d 165.37, 134.17, 130.27,
123.11, 60.50, 50.92, 47.78, 29.93, 20.35, 13.92; IR (neat) cmꢁ1 1708,
1373, 1176, 1041, 898, 782; HRMS (EI): 260.1151 (calcd for
4.6.8. trans-N-(2,3-Diphenylaziridin-1-yl)-phthalimide
(2i).20 1H
C
14H16N2O3: 260.1161).
NMR (400 MHz, CDCl3): d 7.64e7.54 (m, 6H), 7.42e7.31 (m, 5H),
7.24e7.23 (m, 3H), 4.93 (d, J¼4 Hz, 1H), 3.96 (d, J¼4 Hz, 1H); 13C
4.6.4. 2-(2-(Hydroxyl(phenyl)methyl)aziridine-1-yl)-isoindoline-1,3-
dione (2d). 1H NMR (400 MHz, CDCl3):
NMR (100 MHz, CDCl3): d 165.51, 136.58, 133.86, 131.29, 130.16,
d
7.78 (dd, J¼5.6, 3.2 Hz, 2H),
129.37, 128.71, 128.60, 128.22, 128.13, 127.23, 122.86, 53.59, 46.52;
IR (neat) cmꢁ1 2923, 1716, 1372, 896, 749, 698; HRMS (ESI [MþH]):
341.1275 (calcd for C22H17N2O2: 341.1285).
7.70 (dd, J¼5.6, 3.2 Hz, 2H), 7.45e7.43 (m, 2H), 7.38e7.34 (m, 2H),
7.32e7.28 (m, 1H), 4.45 (br s, 1H), 4.33 (d, J¼8 Hz, 1H), 2.82e2.77
(m, 1H), 2.64e2.57 (m, 2H); 13C NMR (100 MHz, CDCl3):
d 165.44,
139.90, 134.35, 130.18, 128.56, 128.11, 126.18, 123.33, 75.77, 50.55,
35.83; IR (neat) cmꢁ1 2992, 1711, 1378, 1049, 708; HRMS (ESI
[MþNa]): 317.0899 (calcd for C17H14N2O3Na: 317.0897).
4.6.9. 2-(7-Azabicyclo[4.1.0]heptan-7-yl)isoindoline-1,3-dione
(2j).14,19 1H NMR (400 MHz, CDCl3):
d 7.71e7.68 (m, 2H), 7.63e7.60
(m, 2H), 2.70 (d, J¼4 Hz, 2H), 2.21e2.18 (m, 2H), 1.93 (br s, 2H),
1.39e1.34 (m, 2H), 1.28e1.22 (m, 2H); 13C NMR (100 MHz, CDCl3):
4.6.5. 2-(2-Hydroxy-7-azabicyclo[4.1.0]heptan-7-yl)-isoindoline-1,2-
d
165.15, 133.76, 130.62, 122.74, 43.81, 23.09, 20.04; IR (neat) cmꢁ1
dione (2e). 1H NMR (400 MHz, CDCl3):
d
7.74 (dd, J¼5.6, 3.2 Hz, 2H),
2937, 1715, 1458, 178, 712; HRMS (EI): 242.1053 (calcd for
C14H14N2O2: 242.1055).
7.67e7.65 (m, 2H), 4.09e4.06 (m, 1H), 3.56 (d, J¼7.2, 1H), 3.19 (ddd,
J¼7.4, 4.8, 2.4 Hz, 1H), 2.78 (dd, 7.6, 4 Hz, 1H), 2.02e1.98 (m, 2H),
1.70e1.67 (m, 1H), 1.57e1.54 (m, 1H), 1.41e1.32 (m, 1H), 1.22e1.17
4.6.10. 2-(7-Azabicyclo[4.1.0]hept-3-en-7-yl)isoindoline-1,3-dione
(2k).24 1H NMR (400 MHz, CDCl3):
7.71e7.70 (m, 2H), 7.63e7.62
(m, 1H); 13C NMR (100 MHz, CDCl3):
d
165.42, 134.17, 130.23, 123.11,
d
66.69, 49.17, 45.89, 29.05, 21.72, 19.18; IR (neat) cmꢁ1 2938, 1704,
(m, 2H), 6.20e6.18 (m,1H), 5.91e5.88 (m,1H), 3.13 (d, J¼6.8 Hz,1H),
1373, 1153, 790; HRMS (ESI [MþH]): 259.1074 (calcd for
2.84 (br s, 1H), 2.53e2.48 (m, 1H), 2.17e2.11 (m, 1H), 2.07e1.99 (m,
C
14H15N2O3: 259.1077).
1H),1.68e1.60 (m,1H); 13C NMR (100 MHz, CDCl3):
d 164.97,133.86,
132.13, 130.34, 122.82, 121.34, 46.23, 40.23, 20.89, 18.17; IR (neat)
cmꢁ1 3034, 2922, 1711, 1463, 1380, 1151, 787; HRMS (EI): 240.0905
(calcd for C14H12N2O2: 240.0899).
4.6.6. 2-((3aR,4S,5aR,6aR,6bS)-4-Hydroxy-2,2-dimethyldihydro-
3aH-[1,3]dioxolo[40,50:3,4]benzo[1,2-b]azirin-6(4H,6aH,6bH)-yl)iso-
indoline-1,3-dione (2f). 1H NMR (400 MHz, CDCl3):
d
7.75 (dd, J¼5.6,
3.2 Hz, 2H), 7.67 (dd, J¼5.6, 3.2 Hz, 2H), 4.9 (d, J¼6 Hz, 1H), 4.29 (dd,
J¼5.8, 3.4 Hz, 1H), 3.94 (d, J¼3.2 Hz, 1H), 3.75 (d, J¼11.2 Hz, 1H), 3.10
(d, J¼7.2 Hz, 1H), 2.96 (d, J¼7.6 Hz, 1H), 2.51e2.47 (m, 1H), 2.29 (dd,
J¼4, 2.4 Hz,1H),1.41 (s, 3H),1.35 (s, 3H); 13C NMR (100 MHz, CDCl3):
4.6.11. 2-(1-Methyl-7-azabicyclo[4.1.0]heptan-7-yl)isoindoline-1,3-
dione (2l).19 1H NMR (400 MHz, CDCl3):
d 7.66e7.58 (m, 4H), 2.82
(d, J¼5.2 Hz, 1H), 2.15e2.06 (m, 2H), 1.95e1.94 (m, 1H), 1.65e1.58
(m, 1H), 1.37e1.34 (m, 2H), 1.25e1.17 (m, 5H); 13C NMR (100 MHz,
d
164.48, 134.22, 130.21, 123.22, 109.51, 74.78, 70.07, 64.7, 44.66,
CDCl3): d 166.1, 133.64, 130.72, 122.54, 48.19, 47.10, 30.29, 23.53,
43.34, 27.42, 25.23, 23.75; IR (neat) cmꢁ1 2913, 1778, 1723, 1467,
20.23, 20.07, 19.91; IR (neat) cmꢁ1 2934, 1726, 1370, 1147, 711;
HRMS (EI): 256.1206 (calcd for C15H16N2O2: 256.1212).
1376, 1265, 708; HRMS (ESI [MþH]): 331.12882 (calcd for
C
17H19N2O5: 331.12885). Single crystals of product 2f suitable for X-
ray crystallographic analysis were obtained by slow crystallization
from dichloromethane/hexane solution. CCDC number for 2f is
994392. Crystal data for 2f; empirical formula¼C17H18N2O5, for-
4.6.12. 1-Aminophthalimide-2-6,6a-dihydroindeno[1,2-b]aziridine
(2m).19 1H NMR (400 MHz, CDCl3)
d
7.78 (dd, J¼5.2, 3.2 Hz, 2H),
7.68 (dd, J¼5.4, 3.0 Hz, 3H), 7.24 (br s, 3H), 4.15 (d, J¼5.2 Hz, 1H),
mula
weight¼330.33,
temperature¼296
(2)
K,
3.77 (dd, J¼5.0 Hz, 1H), 3.49 (d, J¼18 Hz, 1H), 3.27 (dd, J¼17.8,
wavelength¼1.54178 A, Crystal system¼orthorhombic, space
4.6 Hz, 1H); 13C NMR (100 MHz, CDCl3):
d 165.11, 143.13, 138.88,
ꢀ
ꢀ
group¼P 21 21 21, unit cell dimensions a¼6.8269 (2) A, b¼10.9827
134.05, 130.52, 128.62, 126.79, 125.54, 125.33, 123.05, 53.32, 48.79,
35.1; IR (neat) cmꢁ1 2920,1714,1374,1140, 707; HRMS (ESI [MþH]):
277.0976 (calcd for C17H13N2O2: 277.0972).
(4) A, c¼21.5999 (7) A,
a
¼90ꢀ,
b
¼90ꢀ,
g
¼90ꢀ, volume¼1619.51
ꢀ
ꢀ
(9) A , Z¼4, density (calculated)¼1.351 Mg/m3, absorption
3
ꢀ
coefficient¼0.841
mmꢁ1
mm3,
,
F(000)¼692,
theta range
crystal
data
size¼0.48ꢂ0.12ꢂ0.04
for
4.6.13. 3-Phthalimido-3-azatricyclo[3.2.1.02,4]-octane
(2o).25 1H
collection¼4.09e67.35ꢀ, index ranges¼ꢁ8ꢃhꢃ4, ꢁ13ꢃkꢃ12,
NMR (400 MHz, CDCl3): 7.73e7.71 (m, 2H), 7.64e7.62 (m, 2H),
d
ꢁ25ꢃlꢃ25,
reflections
collected¼24,722,
Independent
2.77 (br s, 2H), 2.73 (br s, 2H), 1.59e1.55 (m, 1H), 1.47 (d, J¼8.8 Hz,
reflections¼2890 [R(int)¼0.0351], completeness to theta (67.35ꢀ)¼
99.6%, absorption correction¼semi-empirical from equivalents,
max. and min. transmission¼0.9671 and 0.6883, refinement
method¼full-matrix least-squares on F2, data¼2890, restraints¼0,
parameters¼222, goodness-of-fit on F2¼0.997, Final R indices
2H), 1.26e1.24 (m, 2H), 0.78 (d, J¼10 Hz, 1H); 13C NMR (100 MHz,
CDCl3): d 165.33, 133.83, 130.47, 122.78, 45.15, 36.21, 27.69, 26.11; IR
(neat) cmꢁ1 2959, 1711, 1376, 1135, 704; HRMS (EI): 254.1051 (calcd
for C15H14N2O2: 254.1055).
[I>2sigma(I)] R1¼0.0384, wR2¼0.1131,
R
indices (all data)
4.6.14. Methyl
4-((1-(1,3-dioxoisoindolin-2-yl)aziridin-2-yl)me-
R1¼0.0398, wR2¼0.1150, absolute structure parameter¼0.0(3),
thoxy)benzoate (2p). 1H NMR (400 MHz, CDCl3):
d
7.98 (d, J¼8.8 Hz,
extinction coefficient¼0.0028(5), largest diff. peak and hole¼0.395
2H), 7.77 (dd, J¼5.8, 3.0 Hz, 2H), 7.68 (dd, J¼5.2, 3.2 Hz, 2H), 6.98 (d,
J¼9.2 Hz, 2H), 4.47 (dd, J¼10.6, 4.6 Hz, 1H), 4.21 (dd, J¼11, 5 Hz, 1H),
3.86 (s, 3H), 3.07e3.03 (m, 1H), 2.68e2.61 (m, 2H); 13C NMR
ꢀꢁ3
and ꢁ0.177 e A
.
4.6.7. 2-(2-(Benzyloxy)-7-azabicyclo[4.1.0]heptan-7-yl)isoindoline-
1,3-dione (2g). 1H NMR (400 MHz, CDCl3):
7.75 (dd, J¼5.4, 3.0 Hz,
(100 MHz, CDCl3):
131.6, 130.25, 123.53, 123.13, 114.29, 67.41, 51.81, 40.56, 35.69; IR
d 167.84, 166.74, 164.96, 162.14, 134.22, 134.14,
d